Saudi Arabia q-PCR Reagents Market – Industry Trends and Forecast to 2030

Saudi Arabia q-PCR Reagents Market Analysis and Insights

The rising public awareness regarding chronic and communicable disorders has enhanced the demand for the market. The major market players focus on various product launches and approvals during this crucial period. In addition, the increase in improved and advanced technology also contributes to the rising demand for the market.

The Saudi Arabia q-PCR Reagents market is expected to grow in the forecast period of 2023 to 2030 due to the rise in chronic diseases. The high funding for research activities by the government and other bodies is also expected to drive market growth. Along with this, manufacturers are engaged in R&D activity for launching novel products in the market. However, the high cost of the products is expected to restrain the market growth. The growing demand for better quality healthcare for communicable disorders and the rising adoption of personalized medicine is expected to boost the market growth. However, the operational barriers faced in conducting diagnostic tests are expected to challenge market growth.

Data Bridge Market Research analyzes that the Saudi Arabia q-PCR reagents market is expected to reach a value of USD 41,798.44 thousand by 2030, at a CAGR of 8.3% during the forecast period of 2023 to 2030.

Market Definition

q-PCR reagents are used in the simultaneous amplification and detection/quantification of nucleic acids using the polymerase chain reaction (PCR). These reagents are used in different applications such as research, diagnosis, and forensics. They are also used for the detection of viruses, genetic stability testing, and others. The main advantage of qPCR is that it allows you to determine the initial number of copies of template DNA (the amplification target sequence) with accuracy and high sensitivity over a wide dynamic range.

Saudi Arabia q-PCR Reagents Market Dynamics

This section deals with the understanding of market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:

Drivers

• Increasing Prevalence of Chronic and Communicable Diseases

Chronic diseases include cardiac diseases, cancer, and diabetes, which are the leading causes of death and disability in many countries around the globe. q-PCR reagents are essential for the diagnosis of chronic diseases such as human Immuno Deficiency Virus (HIV) and malaria. Both conditions have non-specific symptoms. The q-PCR kits and mixers contain all the necessary PCR reagents for rapid, sensitive, and reproducible real-time detection of HIV and other diseases using highly specific primer pairs.

• Increase in Geriatric Population

The geriatric population is susceptible to chronic and malignant diseases. The non-specific antibodies are more common in the elderly population. The diagnosis through q-PCR reagents is important for the elderly population as it provides early diagnosis which is crucial to prevent the extensive spread of the disease since the test is non-invasive and aids in determining antigen detection in infectious chronic diseases. Since the geriatric population is increasing, the need for q-PCR reagents will also increase.

Restraint

• Stringent Rules and Regulation

The commercialization of reagents and products by various key market players is facilitated by compliance with the regulatory frameworks established in the country. The rapid development of privacy policies and regulations being made by SFDA is restraining the market growth. The regulatory authority in charge of regulating the registration and endorsement of medical equipment, including PCR reagents, in Saudi Arabia is known as the Saudi Food and Drug Authority. The SFDA has rules for product registration, labeling, and quality control that manufacturers and distributors of PCR reagents must follow, which restrains market growth.

Opportunity

• Rise in Government Funding for Healthcare

The government, federations, and major market players are creating opportunities across developing countries. These initiatives by the players and government are helping the users to reach out to take advantage of the policies made for low-income and developing nations and making them aware of the diseases that are preventable if diagnosed earlier.

Investments in medical R&D may increase as healthcare spending rises. More studies are conducted in the areas of genetic research, illness monitoring, and diagnostics, which may increase demand for q-PCR reagents. Healthcare facilities may increase the number and type of clinical tests they offer as they develop and enhance their services, which provides the opportunity for market growth.

Challenge

• Lack of Skilled Workforce

q-PCR technology is continuously advancing and manufacturers are continuously engaged in R&D activities for launching advanced q-PCR which require highly skilled and certified professionals to operate it. Handling reagents and maintaining the PCR reactions is not a simple task. It is a vast process that requires proper knowledge, and experience so that the result conducted will be accurate and proper. However, this shortage in the professional and skilled workforce has decreased the market for q-PCR reagents.

The requirement for skilled and certified professionals is a big challenge for the market. The q-PCR is a complex process and the devices have advanced features that require skilled professionals to operate them to provide safe such as effective services to patients.

Recent Developments

• In December 2021, Thermo Fisher Scientific Inc. announced that they have completed the acquisition of PPD, Inc. a leading Saudi Arabia provider of clinical research services to the biopharma and biotech industry. This acquisition has helped the company to increase its product portfolio and sales.
• In September 2021, Agilent Technologies, Inc. announced the signing of a worldwide distribution agreement with Visiopharm, enabling Agilent to co-market Visiopharm’s portfolio of CE-IVD marked artificial intelligence (AI)-driven precision pathology software and other products. This has increased the company’s product reach.
• In September 2021, Bio-Rad Laboratories, Inc. announced the partnership with Seegene, Inc., a Saudi Arabia leader in multiplex molecular diagnostics, for the clinical development and commercialization of infectious disease molecular diagnostic products. This has increased the company’s product portfolio.
• In June 2021, Agilent Technologies, Inc. announced the launch of three InfinityLab Bio LC systems specifically developed to meet the needs of the biopharma industry which include instruments, columns, reagents, and supplies that seamlessly integrate with Agilent OpenLab and MassHunter software, and CrossLab services to maximize efficiency in biopharma labs. This has increased the company’s sales and product portfolio.
• In July 2020, Thermo Fisher Scientific Inc. announced the launch of the Applied Biosystems QuantStudio Absolute Q Digital PCR System, the first fully integrated digital PCR (dPCR) system designed to provide highly accurate and consistent results within 90 minutes. This has increased the company’s revenue and product portfolio.

Saudi Arabia q-PCR Reagents Market Scope

The Saudi Arabia q-PCR reagents market is segmented into four notable segments based on type, application, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

Type

• Reagents
• Consumables

On the basis of type, the market is segmented into reagents and consumables.

Application

• Clinical
• Research
• Food Product Safety Testing
• Forensics
• Others

On the basis of application, the market is segmented into clinical, research, food product safety testing, forensics, and others.

End User

• Hospitals
• Diagnostic Centres
• Pharmaceutical and Biopharmaceutical Companies
• Research & Academic Institute
• Clinical Research Organization
• Veterinary Labs
• Forensic Laboratories
• Others

On the basis of end user, the market is segmented into hospitals, diagnostic centres, pharmaceutical and biopharmaceutical companies, research & academic institute, clinical research organization, veterinary labs, forensic laboratories, and others.

Distribution Channel

• Direct Tender
• Retail Sales
• Others

On the basis of distribution channel, the market is segmented into direct tender, retail sales, and others.   

Competitive Landscape and Saudi Arabia q-PCR Reagents Market Share Analysis

The Saudi Arabia q-PCR reagents market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, and technology lifeline curve. The above data points provided are only related to the company’s focus on the Saudi Arabia q-PCR reagents market.

Some of the major market players operating in the Saudi Arabia q-PCR reagents market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Quantabio, Sino Biological Inc., QIAGEN, TAKARA HOLDINGS INC, Enzo Biochem Inc., meridian BIOSCIENCE, Tonbo Biosciences (A subsidiary of Cytek Biosciences), Norgen Biotek Corp., among others.

SKU-70246